A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
సెన్సెక్స్
77,569.39
▲ +1.08%
నిప్టీ
24,206.90
▲ +1.02%
బంగారం
₹ 13,275/gm
సిల్వర్
₹ 2,45,000/kg
పెట్రోల్
₹ 115.69
డీజిల్
₹ 103.82
ఎల్పీజీ
₹ 994.00
ముడి చమురు
$ 77.02
USD
₹ 95.35
సెన్సెక్స్
77,569.39
▲ +1.08%
నిప్టీ
24,206.90
▲ +1.02%
బంగారం
₹ 13,275/gm
సిల్వర్
₹ 2,45,000/kg
పెట్రోల్
₹ 115.69
డీజిల్
₹ 103.82
ఎల్పీజీ
₹ 994.00
ముడి చమురు
$ 77.02
USD
₹ 95.35
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
101.46% ↑
NAV (₹) on 09 Jul 2026
46.92
1 Day NAV Change
0.86%
Risk Level
Very High Risk
Rating
-
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by ICICI Prudential Asset Management Co. Ltd.. Launched on 25 Jun ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
25 Jun 2018
Min. Lumpsum Amount
₹ 5,000
Fund Age
8 Yrs
AUM
₹ 6,453.52 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.31%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 6,453.52 Cr
Equity
489.16%
Debt
0.06%
Money Market & Cash
15.32%
Other Assets & Liabilities
1.05%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 86.31% |
| Hospitals & Medical Services | 9.13% |
| Treps/Reverse Repo | 5.18% |
| Insurance Distributor | 1.38% |
| Chemicals - Organic - Others | 1.19% |
| Chemicals - Speciality | 1.02% |
| Medical Equipment & Accessories | 0.80% |
| Cash | 0.01% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 12.09% | ₹ 780.51 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 7.70% | ₹ 496.84 | Pharmaceuticals |
| Cipla Ltd. | 7.45% | ₹ 480.68 | Pharmaceuticals |
| Mankind Pharma Ltd. | 7.03% | ₹ 453.64 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 6.06% | ₹ 391.33 | Pharmaceuticals |
| TREPS | 5.18% | ₹ 334.20 | Others |
| Biocon Ltd. | 4.71% | ₹ 304.27 | Pharmaceuticals |
| Cohance Lifesciences Ltd. | 4.37% | ₹ 282.16 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 4.08% | ₹ 263.44 | Pharmaceuticals |
| Medplus Health Services Ltd | 3.86% | ₹ 249.05 | Pharmaceuticals |
| MAX Healthcare Institute Ltd | 3.36% | ₹ 217.15 | Hospitals & Medical Services |
| Lupin Ltd. | 3.06% | ₹ 197.28 | Pharmaceuticals |
| Syngene International Ltd. | 2.99% | ₹ 192.73 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 2.40% | ₹ 154.56 | Hospitals & Medical Services |
| Abbott India Ltd. | 2.14% | ₹ 137.96 | Pharmaceuticals |
| Akums Drugs and Pharmaceuticals Ltd. | 2.01% | ₹ 129.40 | Pharmaceuticals |
| Pfizer Ltd. | 1.98% | ₹ 127.57 | Pharmaceuticals |
| J.B.Chemicals & Pharmaceuticals Ltd. | 1.94% | ₹ 125.43 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 1.92% | ₹ 124.15 | Pharmaceuticals |
| Alivus Life Sciences Ltd. | 1.77% | ₹ 114.04 | Pharmaceuticals |
| Alembic Pharmaceuticals Ltd. | 1.76% | ₹ 113.46 | Pharmaceuticals |
| Entero Healthcare Solutions | 1.74% | ₹ 112.46 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 1.54% | ₹ 99.09 | Hospitals & Medical Services |
| Rainbow Childrens Medicare Ltd | 1.44% | ₹ 93 | Hospitals & Medical Services |
| Blue Jet Healthcare Ltd. | 1.40% | ₹ 90.24 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd | 1.38% | ₹ 88.75 | Insurance Distributor |
| Hikal Ltd. | 1.21% | ₹ 78.11 | Pharmaceuticals |
| Fine Organic Industries Ltd. | 1.19% | ₹ 76.86 | Chemicals - Organic - Others |
| Aarti Drugs Ltd. | 1.10% | ₹ 70.96 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Ltd | 1.02% | ₹ 66.06 | Chemicals - Speciality |
| Windlas Biotech Ltd. | 0.96% | ₹ 61.69 | Pharmaceuticals |
| Laxmi Dental Ltd. | 0.80% | ₹ 51.34 | Medical Equipment & Accessories |
| Astrazeneca Pharma India Ltd. | 0.78% | ₹ 50.31 | Pharmaceuticals |
| FDC Ltd. | 0.77% | ₹ 49.61 | Pharmaceuticals |
| Shilpa Medicare Ltd. | 0.71% | ₹ 46.03 | Pharmaceuticals |
| Indoco Remedies Ltd. | 0.47% | ₹ 30.35 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd | 0.39% | ₹ 25.36 | Hospitals & Medical Services |
| Anthem Biosciences Ltd | 0.25% | ₹ 15.95 | Pharmaceuticals |
| Cash Margin - Derivatives | 0.01% | ₹ 0.41 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 8.99% | 9.19% | 14.02% | 26.30% |
| Category returns | 3.63% | 3.89% | 5.96% | 22.44% |
Fund Objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied ... Read more
AMC Details
Name
ICICI Prudential Asset Management Co. Ltd.
Date of Incorporation
12 Oct 1993
CEO
Mr. Nimesh Shah
CIO
Mr. S Naren
Type
Pvt.Sector-Joint Venture (Indian)
Address
One BKC, A-Wing,
13th Floor,
Bandra Kurla Complex, Mumbai, Maharashtra, India - 400051
Website
http://www.icicipruamc.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.04 | 157.07% | 299.60% | 0.00% | ₹1,256 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.04 | 157.07% | 299.60% | 0.00% | ₹1,256 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.04 | 157.07% | 299.60% | 0.00% | ₹1,256 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.73 | 153.59% | 283.35% | 0.00% | ₹1,256 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.73 | 153.59% | 283.35% | 0.00% | ₹1,256 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.73 | 153.59% | 283.35% | 0.00% | ₹1,256 | 2.60% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 14.65% | 192.83% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 14.65% | 192.83% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 14.65% | 192.83% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.06 | 13.50% | 183.21% | 0.00% | ₹10,529 | 1.80% |
Very High
|
Top Funds from ICICI Prudential Asset Management Co. Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ICICI Prudential Silver ETF
ETF
Regular
|
₹221.66 | 105.82% | 210.74% | 0.00% | ₹15,986 | 0.40% |
Very High
|
|
ICICI Prudential Silver ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹34.10 | 103.54% | 206.20% | 0.00% | ₹6,998 | 0.20% |
Very High
|
|
ICICI Prudential Silver ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹34.10 | 103.54% | 206.20% | 0.00% | ₹6,998 | 0.20% |
Very High
|
|
ICICI Prudential Silver ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹34.10 | 103.54% | 206.20% | 0.00% | ₹6,998 | 0.20% |
Very High
|
|
ICICI Prudential Silver ETF FOF
Fund of Funds
Regular
|
₹33.37 | 102.56% | 202.11% | 0.00% | ₹6,998 | 0.65% |
Very High
|
|
ICICI Prudential Silver ETF FOF
Fund of Funds
Regular
|
₹33.37 | 102.56% | 202.11% | 0.00% | ₹6,998 | 0.65% |
Very High
|
|
ICICI Prudential Silver ETF FOF
Fund of Funds
Regular
|
₹33.37 | 102.56% | 202.11% | 0.00% | ₹6,998 | 0.65% |
Very High
|
|
ICICI Prudential Gold ETF
ETF
Regular
|
₹122.24 | 48.17% | 138.48% | 187.41% | ₹27,578 | 0.49% |
High
|
|
ICICI Prudential Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹45.86 | 48.31% | 137.55% | 186.30% | ₹6,856 | 0.18% |
High
|
|
ICICI Prudential Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹45.86 | 48.31% | 137.55% | 186.30% | ₹6,856 | 0.18% |
High
|
FAQs
What is the current NAV of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth is ₹46.92 as of 09 Jul 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth?
The Assets Under Management (AUM) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth is ₹6,453.52 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth?
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth has delivered returns of 9.19% (1 Year), 26.30% (3 Year), 16.85% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth?
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth?
The minimum lumpsum investment required for ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
Mutual Funds: మిడ్, ప్లెక్సీ క్యాప్ మ్యూచువల్ ఫండ్లలోకి పెరిగిన పెట్టుబడులు.. -
Mutual Fund: రూ.లక్షను రూ.2.8 లక్షలు చేసిన మ్యూచువల్ ఫండ్ ఇదే..! -
FD Vs Mutual Fund: ఫిక్స్డ్ డిపాజిట్, మ్యూచువల్ ఫండ్.. ఏది బెటర్..! -
చరిత్ర సృష్టించిన భారత మ్యూచువల్ ఫండ్ ఇండస్ట్రీ.. తొలిసారిగా ఎఫ్ఐఐలను అధిగమించి సరికొత్త రికార్డు.. -
Mutual Funds: నెలకు రూ.10 వేలతో రూ.40 లక్షలు మీ సొంతం..! -
పీజీఐఎం ఇండియా కీలక నిర్ణయం: గ్లోబల్ ఫండ్లలో కొత్త SIPలు నిలిపివేత! -
జెరోధా కొత్త ఫండ్ ఆఫర్: రిటైర్మెంట్ ప్లానింగ్ కోసం ఇదే చివరి అవకాశం, ఇప్పుడే ఇన్వెస్ట్ చేయండి! -
ఇంటర్నేషనల్ మ్యూచువల్ ఫండ్స్ SIPలు ఆగిపోయాయా? ఇన్వెస్టర్లు ఇప్పుడు ఏం చేయాలి? -
మిరే అసెట్ కొత్త మిడ్క్యాప్ ఫండ్: ఈటీఎఫ్ vs ఎఫ్ఓఎఫ్ - మీ పెట్టుబడికి ఏది బెస్ట్? -
HDFC నిఫ్టీ ఆటో ఇండెక్స్ ఫండ్ NFO: నేడే చివరి అవకాశం, తక్కువ పెట్టుబడితో భారీ లాభాల కోసం ఇలా చేయండి!
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+